Bumper Offer - Urjas oil Just @ Rs. 1
Levesam 250 Tablet (10) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Epilepsy. Other than this, Levesam 250 Tablet (10) has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Levesam 250 Tablet (10) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Levesam 250 Tablet (10) include Fatigue, Headache, Drowsiness. Apart from the aforementioned side effects, Levesam 250 Tablet (10) can also lead to other problems, which have been listed below. Usually, these side effects of Levesam 250 Tablet (10) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Levesam 250 Tablet (10)'s effect during pregnancy is Moderate and Mild while nursing. Further, the section on Levesam 250 Tablet (10) related warnings talks about Levesam 250 Tablet (10)'s effects on the liver, heart and kidney.
Other contraindications of Levesam 250 Tablet (10) have been discussed in the sections ahead.
Additionally, Levesam 250 Tablet (10) may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Levesam 250 Tablet (10), it is important to know that it is not safe while driving, and is not habit-forming.
Levesam 250 Tablet (10) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levesam 250 Tablet (10) is used -
Moderate
Mild
Common
Is the use of Levesam 250 Tablet (10) safe for pregnant women?
Pregnant women may experience moderate side effects from Levesam. It is best to stop taking Levesam immediately and inform your doctor if you notice any discomfort.
Is the use of Levesam 250 Tablet (10) safe during breastfeeding?
Levesam may have very limited harmful effects for breastfeeding women.
What is the effect of Levesam 250 Tablet (10) on the Kidneys?
Very few cases of side effects of Levesam on kidney have been reported.
What is the effect of Levesam 250 Tablet (10) on the Liver?
Levesam has very mild side effects on the liver.
What is the effect of Levesam 250 Tablet (10) on the Heart?
Levesam is not harmful for the heart.
Levesam 250 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levesam 250 Tablet (10) unless your doctor advises you to do so -
Is this Levesam 250 Tablet (10) habit forming or addictive?
Levesam 250 Tablet (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Levesam 250 Tablet (10) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Levesam 250 Tablet (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Levesam 250 Tablet (10) works for mental disorders.
Interaction between Food and Levesam 250 Tablet (10)
You can take Levesam 250 Tablet (10) with food.
Interaction between Alcohol and Levesam 250 Tablet (10)
Consuming Levesam 250 Tablet (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
